Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 Biomarker disease BEFREE A screening method optimized to discover cytotoxic compounds selective for MLL-rearranged leukemia identified CCI-006 as a novel inhibitor of MLL-rearranged and CALM-AF10 translocated leukemias that share common leukemogenic pathways. 30670779 2019
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 Biomarker disease BEFREE CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice. 31141090 2019
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 GeneticVariation disease BEFREE AF10 is a transcription factor that has been implicated in the development of leukemia following chromosomal rearrangements between the AF10 gene and one of at least two other genes, MLL and CALM. 23284727 2012
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 Biomarker disease BEFREE Leukemias induced by the CALM-AF10 (MF) mutant recapitulated multiple aspects of full-length CALM-AF10-induced leukemia, including aberrant Hoxa cluster upregulation, a characteristic molecular lesion of CALM-AF10 leukemias. 21681188 2011
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 Biomarker disease BEFREE However, the long latency of leukemogenesis of CALM-AF10 transgenic mice suggests that the direct effects of fusion oncogene are not sufficient for the induction of leukemia. 19443658 2009
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 AlteredExpression disease BEFREE The expression of CALM/AF10 in primary murine bone marrow cells results in the development of an aggressive leukemia in a murine bone marrow transplantation model. 18037964 2008
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 Biomarker disease BEFREE This review discusses the normal structure and function of CALM and AF10, describes the spectrum of clinical findings seen in patients with CALM-AF10 fusions, summarizes recently published CALM-AF10 mouse models and highlights the role of HOXA cluster gene activation in CALM-AF10 leukemia. 18094714 2008
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.080 Biomarker disease BEFREE We conclude that fusion of CALM and AF10 is a recurring abnormality in both lymphoid and myeloid leukemias of various types including AML-M5, and that the breakpoints in the two types of leukemia do not differ. 10637483 2000